![Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-022-00732-3/MediaObjects/41408_2022_732_Fig2_HTML.png)
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
![Amyloidosis AL with severe renal and cardiac involvement: a very rare association of terrible prognosis, two case reports | Nefrología Amyloidosis AL with severe renal and cardiac involvement: a very rare association of terrible prognosis, two case reports | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X2013251412002115:11556_108_39794_en_t110.jpg?idApp=UINPBA000064)
Amyloidosis AL with severe renal and cardiac involvement: a very rare association of terrible prognosis, two case reports | Nefrología
![Time course of serum creatinine and free light chains kappa in patient... | Download Scientific Diagram Time course of serum creatinine and free light chains kappa in patient... | Download Scientific Diagram](https://www.researchgate.net/publication/31389389/figure/fig2/AS:277576351272991@1443190767576/Time-course-of-serum-creatinine-and-free-light-chains-kappa-in-patient-3-Open-arrows.png)
Time course of serum creatinine and free light chains kappa in patient... | Download Scientific Diagram
![Durable remission of C3 glomerulonephritis with mycophenolate mofetil - Lioufas - 2017 - Nephrology - Wiley Online Library Durable remission of C3 glomerulonephritis with mycophenolate mofetil - Lioufas - 2017 - Nephrology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/60b54d07-b8a9-43c2-91b1-680682d99d1b/nep12939-fig-0002-m.jpg)
Durable remission of C3 glomerulonephritis with mycophenolate mofetil - Lioufas - 2017 - Nephrology - Wiley Online Library
![Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis](https://www.frontiersin.org/files/Articles/881202/fcdhc-03-881202-HTML-r1/image_m/fcdhc-03-881202-g002.jpg)
Frontiers | Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis
![The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12882-020-01771-3/MediaObjects/12882_2020_1771_Fig1_HTML.png)
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
![Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table2-1.png)
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
![Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table4-1.png)
Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
![Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table3-1.png)
Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
![Amazon.com: KAPPA NUTRITION Creatine Monohydrate Micronized 2.5g (240 Servings) : Health & Household Amazon.com: KAPPA NUTRITION Creatine Monohydrate Micronized 2.5g (240 Servings) : Health & Household](https://m.media-amazon.com/images/W/MEDIAX_792452-T2/images/I/71U6suDwElL.jpg)
Amazon.com: KAPPA NUTRITION Creatine Monohydrate Micronized 2.5g (240 Servings) : Health & Household
![Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/pr5005967/asset/images/large/pr-2014-005967_0009.jpeg)
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
The changes of serum IgA, free kappa/lambda ratio, creatinine and free... | Download Scientific Diagram
![Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study - ScienceDirect Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121025349-gr1.jpg)
Defining New Reference Intervals for Serum Free Light Chains in Individuals with Reduced Kidney Function: Results of the Population- Based on Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM) Study - ScienceDirect
![Children | Free Full-Text | Diagnostic Performance of Height-Estimated Baseline Creatinine in Diagnosing Acute Kidney Injury in Children with Type 1 Diabetes Mellitus Onset Children | Free Full-Text | Diagnostic Performance of Height-Estimated Baseline Creatinine in Diagnosing Acute Kidney Injury in Children with Type 1 Diabetes Mellitus Onset](https://www.mdpi.com/children/children-09-00899/article_deploy/html/images/children-09-00899-g001.png)